PRESTIGE CONSUMER HEALTHCARE INC. Public Float
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Public Float of $2.97 billion as of 2025-09-30, per its 10-K filed 2026-05-14.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-05-14
- 2025-09-30: Entity Public Float $2.97B.
- 2024-09-30: Entity Public Float $3.53B.
- 2023-09-30: Entity Public Float $2.82B.
- 2022-09-30: Entity Public Float $2.45B.
| Period end | Entity Public Float |
|---|---|
| 2025-09-30 | $2.97B 10-K · filed 2026-05-14 |
| 2024-09-30 | $3.53B 10-K · filed 2025-05-09 |
| 2023-09-30 | $2.82B 10-K · filed 2024-05-15 |
| 2022-09-30 | $2.45B 10-K · filed 2023-05-05 |
| 2021-09-30 | $2.80B 10-K · filed 2022-05-06 |
| 2020-09-30 | $1.82B 10-K · filed 2021-05-07 |
| 2019-09-30 | $1.74B 10-K · filed 2020-05-08 |
| 2018-09-30 | $1.95B 10-K · filed 2019-05-13 |
| 2017-09-30 | $2.65B 10-K · filed 2018-05-10 |
| 2016-09-30 | $2.55B 10-K · filed 2017-05-17 |
| 2015-09-30 | $2.38B 10-K · filed 2016-05-17 |
| 2014-09-30 | $1.68B 10-K · filed 2015-05-14 |
| 2013-09-30 | $1.55B 10-K · filed 2014-05-19 |
| 2012-09-30 | $850.60M 10-K · filed 2013-05-17 |
| 2011-09-30 | $453.00M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |